Discover 167 paid clinical trials in Honolulu, Hawaii. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 167
Active & Responsive
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
for
Overweight, Obesity
Location: Honolulu HI, Corvallis OR, Huntington Park CA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07770841
Phase 3, Recruiting
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
for
Healthy Adult Participants
Location: Honolulu HI, San Francisco CA, Portland OR, Seattle WA,
Sponsor: Ecotera Health LLC
Sex: All
Age: 18+
Code: NCT07775495
Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Honolulu HI, San Francisco CA, Santa Rosa CA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07207811
Phase 3, Recruiting
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
for
Sarcoma
Location: Honolulu HI, San Francisco CA, Palo Alto CA,
Sponsor: University of Leicester
Sex: All
Age: 0 - 49
Code: NCT00020566
Phase 3, Recruiting
Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy
for
Polypoidal Choroidal Vasculopathy
Location: Honolulu HI, Aiea HI
Sponsor: Retina Consultants of Hawaii
Sex: All
Age: 25+
Code: NCT01248117
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Comparison of Body and Room Temperature Saline in Urodynamics
for
Urinary Incontinence
Location: Tamc HI
Sponsor: Tripler Army Medical Center
Sex: Female
Age: 18+
Code: NCT00355433
Recruiting
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration